Identification of a Radiosensitivity Molecular Signature Induced by Enzalutamide in Hormone-Sensitive and Hormone-Resistant Prostate Cancer Cells

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-44991-w
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Eyeing Enzalutamide for Hormone-Sensitive Prostate Cancer

Cancer Discovery
Oncology
2019English

Treatment of Hormone‐Resistant Prostate Cancer

Oncologist
Cancer ResearchMedicineOncology
1997English

Molecular Features of Hormone-Refractory Prostate Cancer Cells by Genome-Wide Gene Expression Profiles

Cancer Research
Cancer ResearchOncology
2007English

Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive Prostate Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

‘Charting a New Course for Prostate Cancer’ – Currying Favor for Docetaxel in Hormone-Sensitive Metastatic Prostate Cancer

Expert Review of Anticancer Therapy
OncologyPharmacology
2014English

Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide

Clinical Medicine Insights: Oncology
Oncology
2013English

Hormone-Refractory Prostate Cancer

English

Gonadotropin-Releasing Hormone Induces Apoptosis of Prostate Cancer Cells

Cancer Research
Cancer ResearchOncology
2004English

Chemohormonal Therapy for Metastatic Hormone-Sensitive Prostate Cancer: An Asian Perspective

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy